Performing Electroconvulsive Therapy and Assessing Seizure Efficacy via Pupillary Response
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:22 min • August 29th, 2025
Loading...
Overview
This article demonstrates the procedure for performing electroconvulsive therapy (ECT) in human patients, focusing on the assessment of effective seizure induction through pupillary response. The protocol highlights the use of an automated infrared pupillometer to evaluate sympathetic nervous system activation following ECT-induced seizures.
Key Study Components
Area of Science
- Neuropsychiatry
- Clinical neuroscience
- Electrophysiology
Background
- ECT is a therapeutic intervention for depression and other psychiatric disorders.
- Seizure induction is central to ECT's therapeutic effect.
- Neuronal depolarization and synchronized firing during ECT release excitatory neurotransmitters.
- Seizure activity stimulates the sympathetic nervous system, leading to pupil dilation.
Purpose of Study
- To demonstrate the ECT procedure in a clinical setting.
- To assess seizure effectiveness using pupillary response as an indicator.
- To provide a standardized method for evaluating sympathetic activation post-ECT.
Methods Used
- Application of adhesive pads to the patient's temples for electroconvulsive stimulation.
- Administration of an electrical stimulus, typically set at half the patient's age as a percentage.
- Measurement of pupillary response using an automated infrared pupillometer immediately after seizure cessation.
- Assessment of EEG parameters including ictal regularity, seizure duration, and post-ictal suppression.
Main Results
- Effective seizure induction is associated with a lack of pupil constriction in response to light, indicating prolonged sympathetic activation.
- Pupillary response provides a rapid, non-invasive assessment of seizure adequacy.
- EEG measurements complement pupillometry in evaluating seizure quality.
- Controlled ventilation with 100% oxygen is performed until spontaneous breathing resumes.
Conclusions
- Pupillary response is a useful clinical marker for assessing effective seizure induction during ECT.
- Automated pupillometry offers a standardized, objective method for monitoring sympathetic nervous system activation post-ECT.
- Combining pupillometry with EEG enhances the assessment of ECT efficacy.
Frequently Asked Questions
What is the purpose of using pupillary response in ECT?
Pupillary response serves as a rapid, non-invasive indicator of effective seizure induction and sympathetic nervous system activation following ECT.
How is the electrical stimulus dose determined for ECT?
The initial electrical stimulus dose is typically set at half the value of the patient's age, expressed as a percentage.
What does the absence of pupil constriction after light exposure indicate?
It indicates prolonged sympathetic activation and suggests that an adequate seizure has been induced by ECT.
What equipment is used to measure pupillary response?
An automated infrared pupillometer is used to measure maximum resting pupil size and minimum pupil size after light stimulation.
How is seizure activity further assessed after ECT?
Seizure activity is evaluated using EEG to measure ictal regularity, seizure duration, and post-ictal suppression.
Why is controlled ventilation performed after ECT?
Controlled ventilation with 100% oxygen is provided until the patient resumes spontaneous breathing, ensuring adequate oxygenation during recovery.
Executive Industry Relevance
Quantitative assessment of seizure efficacy is critical for translational neuroscience and neuropsychiatric drug discovery. Automated pupillometry following electroconvulsive therapy (ECT) provides a standardized, objective readout of sympathetic activation and seizure adequacy. Integrating such physiological biomarkers enhances predictive confidence and mechanistic de-risking at the interface of clinical and preclinical research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of neurocircuit activation and downstream physiological responses.
- Supports mechanistic de-risking by linking neuronal depolarization to functional sympathetic output.
- Facilitates target validation for neuromodulatory interventions by providing objective seizure efficacy endpoints.
Screening & Assay Development
- Establishes a reproducible, quantitative assay for evaluating seizure induction and sympathetic response.
- Standardizes measurement of pupillary response as a functional biomarker for assay development.
- Enables reliable comparison of intervention efficacy across experimental conditions.
Translational & Preclinical Research
- Aligns physiological readouts with clinical endpoints for translational continuity.
- Supports risk-adjusted advancement of neuromodulatory therapies by providing objective efficacy markers.
- Facilitates integration of EEG and pupillometry data for comprehensive seizure assessment.
Pipeline & Workflow Integration
This method bridges clinical neurostimulation protocols and translational biomarker development, supporting workflows from early discovery through preclinical validation.
- Discovery Biology: Links neuronal activation to measurable sympathetic output, supporting hypothesis testing.
- Screening: Provides standardized, quantitative pupillary response metrics for assay readiness.
- Analytics: Delivers objective measurements of seizure adequacy and sympathetic activation for cross-condition comparison.
- Translational Research: Aligns physiological biomarkers with clinical endpoints for seamless data integration.
- Enterprise Reuse: Offers a scalable, reproducible physiological assay adaptable across neuropsychiatric research models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in seizure efficacy assessment.
- Operational Value: Enhances standardization, reproducibility, and scalability of physiological biomarker measurement.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing objective efficacy endpoints.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of neuromodulatory and neuropsychiatric programs.
Implementation Considerations
- Requires expertise in neurophysiology and clinical neurostimulation protocols.
- Needs access to automated infrared pupillometry and EEG instrumentation.
- Demands cross-team standardization of measurement timing and data interpretation.
- Adaptation may be needed for different patient populations or preclinical models.
- Dependent on immediate post-seizure measurement for optimal data quality.
Biopharma FAQs
Why does null hypothesis testing matter for pupillary response in ECT?
Null hypothesis testing ensures that observed changes in pupillary response are statistically attributable to seizure induction rather than random variation. This strengthens confidence in using pupillometry as a functional biomarker for target validation in neuropsychiatric research.
How does independent variable isolation apply to electrical stimulus dosing?
Isolating the electrical stimulus dose, typically set at half the patient's age, allows for controlled assessment of its direct impact on seizure induction and pupillary response. This supports reproducible evaluation of intervention efficacy within the discovery pipeline.
What do quantitative pupillometer measurements enable in seizure assessment?
Quantitative pupillometer measurements provide objective, reproducible data on sympathetic activation and seizure adequacy. These outputs enable reliable comparison across interventions and support data-driven decision-making in R&D workflows.
Why are replication requirements critical for EEG and pupillometry outputs?
Replication of EEG and pupillometry measurements ensures cross-functional teams can trust the reliability and reproducibility of seizure efficacy assessments. This is essential for collaborative advancement and portfolio triage in neuropsychiatric research.
What statistical analysis capabilities are needed before implementing pupillary response assays?
Robust statistical analysis is required to interpret pupillary response and EEG data, including threshold setting and significance testing. These capabilities are necessary to validate assay performance and support translational decision-making.
09:07
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Related Videos
0 Views
10:08
The Pilocarpine Model of Temporal Lobe Epilepsy and EEG Monitoring Using Radiotelemetry System in Mice
Related Videos
0 Views
06:45
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
Related Videos
0 Views
05:52
Assessment of Excitatory Neurotransmitter Levels in Chronic Epilepsy-Induced Rats
Related Videos
0 Views
12:10
Performing Behavioral Tasks in Subjects with Intracranial Electrodes
Related Videos
0 Views
05:54
Stereo-Electro-Encephalo-Graphy (SEEG) With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Related Videos
0 Views
08:23
A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Related Videos
0 Views
09:06
Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
Related Videos
0 Views
10:51
Chronic Transcranial Electrical Stimulation and Intracortical Recording in Rats
Related Videos
0 Views
04:50
Operative Technique and Nuances for the Stereoelectroencephalographic (SEEG) Methodology Utilizing a Robotic Stereotactic Guidance System
Related Videos
0 Views
Last updated: 4 July 2026